Pharmacochemical Aspects of the Evolution from Erythromycin to Neomacrolides, Ketolides and Neoketolides
Open Access
- 1 January 2020
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Open Journal of Medicinal Chemistry
- Vol. 10 (03), 57-112
- https://doi.org/10.4236/ojmc.2020.103005
Abstract
Antibiotic macrolides are experiencing renewed interest in anti-infective therapy since the advent of ketolides. This therapeutic class was introduced in order to broaden the narrow antibacterial spectrum of macrolides and to cope with the emergence of germs resistant to Erythromycin A and its hemisynthetic derivatives or neomacrolides (Clarithromycin, Roxithromycin, Azithromycin, Dirithromycin). From a pharmacochemical point of view, ketolides were first of all obtained by operating chemical modulations on Erythromycin A to obtain the neomacrolides, then, by replacing the neutral sugar (L-cladinose) in C3 by a ketone function coupled with the creation of an oxazolidinone like heterocycle in C11 and C12 in place of the hydroxyls present in these positions (Telithromycin, Cethromycin, Solithromycin). These modulations have enabled the improvement of the chemical stability of ketolides in gastric acid medium and increase their affinity for the ribosomal target, hence the broadening of their spectrum of action towards Gram positive germs including strains resistant to other macrolides and to neomacrolides. Therefore, the objective of this systematic review is to report the various pharmacochemical aspects undertaken since 1952 in the macrolide series based on the structure of Erythromycin A. These aspects will focus on the pharmacomodulations that have led, year after year, to the optimization of stability, the improvement of the pharmacodynamic and pharmacokinetic profile and that have allowed the development of neomacrolides, ketolides and neoketolides, which are today essential in the management of severe bronchopulmonary infections.Keywords
This publication has 99 references indexed in Scilit:
- Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolidesEuropean Journal of Medicinal Chemistry, 2013
- Synthesis and antibacterial activity of novel ketolides with 11,12-sulfur contained aryl alkyl side chainsEuropean Journal of Medicinal Chemistry, 2011
- Revisiting the structures of several antibiotics bound to the bacterial ribosomeProceedings of the National Academy of Sciences of the United States of America, 2010
- A Facile and Scaleable Synthesis of 3-O-Decladinose-6-methyl-10,11-dehydrate-erythromycin-3-one-2‘-acetate, an Important Intermediate for Ketolide SynthesisOrganic Process Research & Development, 2006
- Synthesis and antibacterial activity of C2-fluoro, C6-carbamate ketolides, and their C9-oximesBioorganic & Medicinal Chemistry Letters, 2005
- Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infectionsDiagnostic Microbiology and Infectious Disease, 1992
- Clinical evaluation of roxithromycin 300 mg once daily as an alternative to 150 mg twice dailyDiagnostic Microbiology and Infectious Disease, 1992
- Pharmacokinetics of Roxithromycin (RU 965)The Journal of Clinical Pharmacology, 1988
- Macrolides. Recent Progress in Chemistry and BiochemistryAngewandte Chemie, 1977
- The structure of the macrolide antibiotic picromycinChemical Communications (London), 1968